Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Price

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
Alimentary Pharmacology & Therapeutics|November 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis BJosef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Ebiomedicine|December 11, 2022
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapyJennifer M Zerbato, Anchalee Avihingsanon, Kasha P Singh, et al.
AIDS (London, England)|July 14, 2018
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1Christina C Chang, Vivek Naranbhai, Jared Stern, et al.
Plos Computational Biology|April 22, 2026
Ensemble forecasts of COVID-19 activity to support Australia's pandemic response: 2020-22Robert Moss, Ruarai J Tobin, Mitchell O'Hara-Wild, et al.
International Journal of Environmental Research and Public Health|February 11, 2023
Inclusion of Cultural and Linguistic Diversity in COVID-19 Public Health Research: Research Design Adaptations to Seek Different Perspectives in Victoria, AustraliaLisa Gibbs, Alexander J Thomas, Alison Coelho, et al.
Wellcome Open Research|February 16, 2026
An oropharyngeal gonorrhoea controlled human infection model: a provisional protocol using a novel <i>Neisseria gonorrhoeae</i> challenge strainEloise Williams, Georgina L Pollock, David J Price, et al.
The Lancet. Microbe|May 21, 2023
Evaluating the role of asymptomatic throat carriage of Streptococcus pyogenes in impetigo transmission in remote Aboriginal communities in Northern Territory, Australia: a retrospective genomic analysisJake A Lacey, Adrian J Marcato, Rebecca H Chisholm, et al.
The Lancet Regional Health. Western Pacific|July 2, 2024
Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological studyGeorge Taiaroa, Doris Chibo, Sophie Herman, et al.
Trials|February 11, 2025
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trialRobert K Mahar, Anna McGlothlin, Michael Dymock, et al.
Nature Microbiology|April 15, 2024
Publisher Correction: Mosquitoes provide a transmission route between possums and humans for Buruli ulcer in southeastern AustraliaPeter T Mee, Andrew H Buultjens, Jane Oliver, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Alimentary Pharmacology & Therapeutics|November 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis BJosef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Ebiomedicine|December 11, 2022
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapyJennifer M Zerbato, Anchalee Avihingsanon, Kasha P Singh, et al.
AIDS (London, England)|July 14, 2018
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1Christina C Chang, Vivek Naranbhai, Jared Stern, et al.
Plos Computational Biology|April 22, 2026
Ensemble forecasts of COVID-19 activity to support Australia's pandemic response: 2020-22Robert Moss, Ruarai J Tobin, Mitchell O'Hara-Wild, et al.
International Journal of Environmental Research and Public Health|February 11, 2023
Inclusion of Cultural and Linguistic Diversity in COVID-19 Public Health Research: Research Design Adaptations to Seek Different Perspectives in Victoria, AustraliaLisa Gibbs, Alexander J Thomas, Alison Coelho, et al.
Wellcome Open Research|February 16, 2026
An oropharyngeal gonorrhoea controlled human infection model: a provisional protocol using a novel <i>Neisseria gonorrhoeae</i> challenge strainEloise Williams, Georgina L Pollock, David J Price, et al.
The Lancet. Microbe|May 21, 2023
Evaluating the role of asymptomatic throat carriage of Streptococcus pyogenes in impetigo transmission in remote Aboriginal communities in Northern Territory, Australia: a retrospective genomic analysisJake A Lacey, Adrian J Marcato, Rebecca H Chisholm, et al.
The Lancet Regional Health. Western Pacific|July 2, 2024
Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological studyGeorge Taiaroa, Doris Chibo, Sophie Herman, et al.
Trials|February 11, 2025
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trialRobert K Mahar, Anna McGlothlin, Michael Dymock, et al.
Nature Microbiology|April 15, 2024
Publisher Correction: Mosquitoes provide a transmission route between possums and humans for Buruli ulcer in southeastern AustraliaPeter T Mee, Andrew H Buultjens, Jane Oliver, et al.
Pageof 22